AMPD1: a novel therapeutic target for reversing insulin resistance

BACKGROUND: Insulin resistance is one of the hallmark manifestations of obesity and Type II diabetes and reversal of this pathogenic abnormality is an attractive target for new therapies for Type II diabetes. A recent report that metformin, a drug known to reverse insulin resistance, demonstrated in...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:BMC Endocr Disord
Main Authors: Cheng, Jidong, Morisaki, Hiroko, Toyama, Keiko, Sugimoto, Naomi, Shintani, Takuya, Tandelilin, Andreas, Hirase, Tetsuaki, Holmes, Edward W, Morisaki, Takayuki
Formáid: Artigo
Teanga:Inglês
Foilsithe: BioMed Central 2014
Ábhair:
Research Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4274759/
https://ncbi.nlm.nih.gov/pubmed/25511531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6823-14-96
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla